Purdue Pharma, maker of OxyContin, reportedly exploring filing for bankruptcy


Facing more than 1,000 lawsuits, Purdue Pharma is exploring filing for bankruptcy, people familiar with the matter told Reuters Monday.
Purdue Pharma makes OxyContin, and the lawsuits allege the company was a major contributor to the nation's opioid crisis by not being up front with doctors and patients about long-term use of the powerful drug. Filing for Chapter 11 bankruptcy would halt those suits, Reuters reports, and Purdue could negotiate with plaintiffs under the supervision of a bankruptcy judge. People with knowledge of the matter said no final decision has been made, and Purdue could decide to continue to fight the lawsuits instead.
Owned by the Sackler family, Purdue denies any wrongdoing and says it placed warning labels approved by the Food and Drug Administration on its bottles, notifying users about the risk of misusing the product. Last June, Massachusetts Attorney General Maura Healey (D) sued Purdue and members of the Sackler family, claiming that while they amassed a fortune of $4.2 billion, they were knowingly misleading the public through deceptive marketing.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
OxyContin sales have dropped to $1.74 billion in 2017 from $2.6 billion in 2012, Symphony Health Solutions reports. The Centers for Disease Control and Prevention says that in 2017, opioids contributed to 47,600 overdose deaths in the United States.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Cracker Barrel crackup: How the culture wars are upending corporate branding
In the Spotlight Is it 'woke' to leave nostalgia behind?
-
'It's hard to discern what it actually means'
Instant Opinion Opinion, comment and editorials of the day
-
Trump lambasts crime, but his administration is cutting gun violence prevention
The Explainer The DOJ has canceled at least $500 million in public safety grants
-
New York court tosses Trump's $500M fraud fine
Speed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year